secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001493152-24-047376
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics receives Nasdaq delisting notice; stock suspension set for Nov 29
--------------------------------------------------------------------------------

- Failed to meet Nasdaq's minimum $2.5M stockholders' equity requirement by Nov 18, 2024, after extension.
- Nasdaq delist determination letter received Nov 19; trading of PTIX stock to suspend on Nov 29 unless appeal.
- Company may request Nasdaq hearing to stay delisting, but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224047376/0001493152-24-047376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224047376/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer